An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States
Clinical trial NCT06029010 · COMPLETED
Trial details
- NCT number
- NCT06029010
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-31
- Primary completion
- 2025-01-27
- Enrollment
- 2326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.